Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis

Shuji Kitahara, Yasuhiro Suzuki, Masae Morishima, Asuka Yoshii, Sachiko Kikuta, Kazuhiko Shimizu, Shunichi Morikawa, Yasufumi Sato, Taichi Ezaki

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Vasohibin-2 (VASH2) has been identified as an endogenous and vascular endothelial growth factor (VEGF)-independent angiogenic factor that is highly expressed in tumor cells. In the present study, we aimed to determine whether pre-existing vascular changes can be used to predict tumor transformation as benign or malignant. We sought to characterize microvascular changes and tumor development in the intestinal tract of ApcMin/+ mice and ApcMin/+/Vash2-/- mice.Methods: ApcMin/+ mice provide a unique orthotopic model for the development of spontaneous adenomatous polyposis and subsequent carcinomas, a phenomenon termed the adenoma-carcinoma sequence. ApcMin/+ mice were mated with Vash2-/- mice with a mixed C57BL/6 background and the resulting pups were screened for the Min mutation and for the Vash2-/- gene by PCR. Intestinal tumors from ApcMin/+ mice and ApcMin/+/Vash2-/- mice were removed and either frozen or epon-embedded for subsequent analyses. For 3-dimensional imaging using confocal laser-scanning microscopy and transmission electron microscopy, cryosections were made, and immunofluorescent staining for various markers was performed.Results: We found that structural abnormalities in tumor vessels from benign tumors resembled those in malignant tumors. In addition, a novel angiogenic factor, vasohibin-2 (VASH2) protein, was detected around tumor blood vessels in late-stage adenomas and adenocarcinomas, but was absent from early-stage adenomas in ApcMin/+ mice. Tumors used to examine endogenous VASH2 (derived from CMT93 colon carcinomas) were less vascularized in Vash2-/- mice and were more regular than those seen in wild-type (WT) mice. In addition, tumors in Vash2-/- mice were smaller than those in WT mice. Furthermore, cross-breeding of mice homozygous for a deletion of Vash2 with mice heterozygous for the APC mutation resulted in animals that showed a significant decrease in the number of polyps in the small intestine.Conclusion: We propose that VASH2 may modulate the onset of tumors in the gastrointestinal tract by regulating tumor angiogenesis.

Original languageEnglish
Article number99
JournalMolecular Cancer
Volume13
Issue number1
DOIs
Publication statusPublished - 2014 May 4

Keywords

  • Angiogenesis
  • Tumor vessel
  • Vasohibin-2

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis'. Together they form a unique fingerprint.

  • Cite this

    Kitahara, S., Suzuki, Y., Morishima, M., Yoshii, A., Kikuta, S., Shimizu, K., Morikawa, S., Sato, Y., & Ezaki, T. (2014). Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis. Molecular Cancer, 13(1), [99]. https://doi.org/10.1186/1476-4598-13-99